Significant breakthroughs have been realized in medical care in modern times. Prostate cancer screening process is a disease control method that detects the presence of the cancer in advance before the symptoms become present. The cancerous growth takes a long while to develop although in some cases it does not develop.
There are two tests commonly used to screen the prostatic cancerous growth which is the Digital-Rectal exam where the doctor inserts a finger in gloves which has been lubricated into the rectum to feel and approximate the prostate gland and feel for any abnormalities such as the lumps.
The prostate specific antigen test which measures the quantity of the antigens specific to prostate and are made by the prostate in the blood. The PSA levels in men are considered to be higher in men with cancerous growth present in them. It may also increased by other factors affecting the glands. Certain medical procedures and medications as well as age and race may also affect the PSA levels.
After the PSA based screening tests a patient may test positive for asymptomatic cancer which may or may not develop over time. This entirely depends on the patient.
The screening is purposed to lower the deaths resulting from the disease. It is also meant to slow down and prevent metastasizing of the disease. Depending on how far the cancerous growth has spread, men detected with the tumor are described in three ways.Those who ultimately result in death in spite of the early detection and treatment, those who survive without the screening procedures and those who end up surviving due to the early detection of the disease and suitable treatment however mild its chances of survival are.
Negative psychological traumas such as constant agitation concerning cancer could affect the PSA test results. These results have uncertainty and are not a hundred percent reliable. The screening procedure may harm the patient and bring about certain effects such as pain, fever, bleeding, infections and urinary difficulties. The treatment procedures such as biopsies could also lead to the patient experiencing some of these effects and are thus advised to consult medical advice as soon as they occur.
PSA screening's long term effects have not been proven yet. Although studies carried out show that their efficiency in reducing the cancers mortality rates have not been successful so far and are minimal. Most men experience the effects of the screen detection and the treatment procedure too early and recurrent and thus are more prone to early deaths.
Most men will experience effects more than the benefits brought about by the screening as well as the treatment process. There's a chance of over treating or over diagnosis of cancerous growth this means that the men will experience adverse effects due to the diagnosis and treatment of the disease which would have probably remained asymptomatic their entire lives.
Balance between the benefits and detriments of early diagnosis and treatment is necessary in determining if there's a chance of survival for the patient or proves to be detrimental to the prostate tumor due to the constant harm caused by the medical procedures.
There are two tests commonly used to screen the prostatic cancerous growth which is the Digital-Rectal exam where the doctor inserts a finger in gloves which has been lubricated into the rectum to feel and approximate the prostate gland and feel for any abnormalities such as the lumps.
The prostate specific antigen test which measures the quantity of the antigens specific to prostate and are made by the prostate in the blood. The PSA levels in men are considered to be higher in men with cancerous growth present in them. It may also increased by other factors affecting the glands. Certain medical procedures and medications as well as age and race may also affect the PSA levels.
After the PSA based screening tests a patient may test positive for asymptomatic cancer which may or may not develop over time. This entirely depends on the patient.
The screening is purposed to lower the deaths resulting from the disease. It is also meant to slow down and prevent metastasizing of the disease. Depending on how far the cancerous growth has spread, men detected with the tumor are described in three ways.Those who ultimately result in death in spite of the early detection and treatment, those who survive without the screening procedures and those who end up surviving due to the early detection of the disease and suitable treatment however mild its chances of survival are.
Negative psychological traumas such as constant agitation concerning cancer could affect the PSA test results. These results have uncertainty and are not a hundred percent reliable. The screening procedure may harm the patient and bring about certain effects such as pain, fever, bleeding, infections and urinary difficulties. The treatment procedures such as biopsies could also lead to the patient experiencing some of these effects and are thus advised to consult medical advice as soon as they occur.
PSA screening's long term effects have not been proven yet. Although studies carried out show that their efficiency in reducing the cancers mortality rates have not been successful so far and are minimal. Most men experience the effects of the screen detection and the treatment procedure too early and recurrent and thus are more prone to early deaths.
Most men will experience effects more than the benefits brought about by the screening as well as the treatment process. There's a chance of over treating or over diagnosis of cancerous growth this means that the men will experience adverse effects due to the diagnosis and treatment of the disease which would have probably remained asymptomatic their entire lives.
Balance between the benefits and detriments of early diagnosis and treatment is necessary in determining if there's a chance of survival for the patient or proves to be detrimental to the prostate tumor due to the constant harm caused by the medical procedures.
About the Author:
You can visit smart-surgery.com for more helpful information about Answers On Prostate Cancer Screening.